The HealthCare Institute of New Jersey’s Pulse 2026 event was featured in a video segment by ROI-NJ, highlighting the state’s role in life sciences and key policy discussions shaping the industry’s future, according to a March 18 announcement.
This coverage is significant as it brings attention to New Jersey’s position as a leader in biopharmaceutical development and the ongoing conversations about innovation, affordability, and global competitiveness. The forum included remarks from Governor Mikie Sherrill, HINJ leadership, and industry stakeholders.
The HealthCare Institute of New Jersey contributes to public health education and supports initiatives that advance biopharmaceutical progress, according to the official website. The organization operates as a nonprofit dedicated to promoting policies that support innovation, patient access, and economic growth within the life sciences sector according to its official website.
HINJ also engages in advocacy at both state and federal levels to influence policies fostering innovation in life sciences according to its official website. It works to build alliances aimed at advancing healthcare innovation and enhancing patient care according to its official website. As a trade association focused on biopharmaceuticals and medical technology, HINJ maintains its headquarters in Princeton, New Jersey according to its official website.
The ROI-NJ video segment captures key themes from the Pulse 2026 forum. The event emphasized New Jersey’s continued commitment to supporting life sciences through collaboration among government leaders, industry representatives, and advocacy organizations.
